Demographic and Clinical Data for All Included Patients
Patient | Age (y) | Sex | Weight (kg) | Disease | Injected 18F-FDG activity (MBq) |
1 | 74 | M | 75 | NSCLC | 215 |
2 | 74 | M | 87 | NSCLC | 270 |
3 | 70 | M | 66 | NSCLC | 195 |
4 | 65 | M | 87 | NSCLC | 265 |
5 | 61 | M | 77 | NSCLC | 231 |
6 | 62 | M | 91 | NSCLC | 275 |
7 | 59 | F | 70 | NSCLC | 220 |
8 | 67 | F | 85 | NSCLC | 260 |
9 | 79 | M | 90 | NSCLC | 265 |
10 | 63 | M | 76 | NSCLC | 205 |
11 | 61 | F | 87 | NSCLC | 260 |
12 | 53 | F | 45 | NSCLC | 135 |
13 | 81 | M | 58 | NSCLC | 160 |
14 | 88 | M | 88 | NSCLC | 264 |
15 | 69 | F | 76 | NSCLC | 220 |
16 | 77 | F | 71 | Lymphoma | 210 |
17 | 48 | M | 82 | Lymphoma | 240 |
18 | 75 | M | 80 | Lymphoma | 245 |
19 | 61 | M | 90 | Lymphoma | 280 |
20 | 62 | F | 68 | Lymphoma | 220 |
21 | 62 | M | 88 | Lymphoma | 260 |
22 | 72 | M | 86 | Lymphoma | 270 |
23 | 70 | F | 58 | Lymphoma | 180 |
24 | 64 | M | 90 | Lymphoma | 280 |
25 | 60 | M | 106 | Esophageal cancer | 305 |
26 | 77 | M | 62 | Esophageal cancer | 200 |
27 | 58 | M | 123 | Esophageal cancer | 380 |
28 | 84 | M | 73 | Esophageal cancer | 220 |
29 | 70 | M | 101 | Esophageal cancer | 290 |
30 | 52 | M | 86 | Esophageal cancer | 260 |